← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2017Last known activity
Feb 28, 2025
Timeline
2010s
- Jun 1, 2013
BioVie Inc.— Founded
2020s
- May 10, 2021
NeurMedix— Acquired
Drugs by trial phase (2 distinct, 8 trials)
Phase 3 (2 own, 0 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (10)
- NCT06757010Lead sponsorPhase 2Feb 28, 2025
- NCT06847191Lead sponsorPhase 2Feb 28, 2025
- NCT05970575CollaboratorPhase 2Aug 21, 2023
- NCT05227820CollaboratorPhase 2Jan 19, 2022
- NCT05083260Lead sponsorPhase 1/Phase 2Nov 30, 2021
- NCT04669028Lead sponsorPhase 3Aug 5, 2021
- NCT04112199Lead sponsorPhase 2/Phase 3Dec 15, 2019
- NCT04112199Study directorPhase 2/Phase 3Dec 15, 2019
- NCT03107091Lead sponsorPhase 2May 1, 2017
- NCT03107091Study directorPhase 2May 1, 2017
Details
- Founded
- Beverley, MA, US Jun 1, 2013
- Last known activity
- Feb 28, 2025